KCT0004579招募中未知
Correlation between severity of illness and electromyography signal using surface EMG in COPD
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 40(Year) 至 o Limit(—)
- 性别
- All
入选标准
- •1.A patient over 40 years of age confirmed with chronic obstructive pulmonary disease (pulmonary function test and clinical diagnosis)
- •2. A person who understands the purpose of this examination and agrees in writing as a participant.
排除标准
- •1. If there is any other disease that can cause death or disability during the first year after admission (e.g. cancer, heart failure, coronary artery disease, cerebrovascular disease, kidney failure, diabetes with severe complications, uncontrolled high blood pressure, etc.)
- •2. If you have a disease that is difficult to walk or improve walking at the time of entry (eg cerebrovascular disease, bone joint disease and other serious nutritional deficiencies)
- •3. If there is a concomitant disease that is not appropriate for the research at the judgment of other physicians
- •4. Others who are unable to participate in the clinical trial based on the researcher's judgment
- •5. Those who did not agree to participate in the research
研究者
相似试验
尚未招募
不适用
Relationship between severity of allergic conjunctival diseases and stressAllergic conjunctival diseasesJPRN-UMIN000045629ihon University80
招募中
不适用
The use of instruments to identify severity and mortality to assess Autonomic Modulation in patients admitted to the ICtraumatic brain injuryS04.9RBR-6qq5zzHospital de Clinicas - Universidade Federal do Triângulo Mineiro
尚未招募
不适用
Severity of covid-19 disease in diabetes mellitus patientsCTRI/2021/03/032453Maulana Azad Medical College
已完成
不适用
Age-related hearing impairment and metabolic syndromeEndocrine, nutritional and metabolic diseaseKCT0001367Asan Medical Center800
尚未招募
不适用
An Observational Study of Disease Severity and Quality of Life in Japanese Patients with Ulcerative ColitisJPRN-UMIN000027750Takeda Pharmaceuticals Company Limited Japan Pharma Business Unit Healthcare Policy & Access300
